The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B 2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting / De Stefano V.; Rocca B.; Tosetto A.; Soldati D.; Petrucci G.; Beggiato E.; Bertozzi I.; Betti S.; Carli G.; Carpenedo M.; Cattaneo D.; Cavalca V.; Dragani A.; Elli E.; Finazzi G.; Iurlo A.; Lanzarone G.; Lissandrini L.; Palandri F.; Paoli C.; Rambaldi A.; Ranalli P.; Randi M.L.; Ricco A.; Rossi E.; Ruggeri M.; Specchia G.; Timillero A.; Turnu L.; Vianelli N.; Vannucchi A.M.; Rodeghiero F.; Patrono C.. - In: BLOOD CANCER JOURNAL. - ISSN 2044-5385. - ELETTRONICO. - 8:(2018), pp. 49-57. [10.1038/s41408-018-0078-3]
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B 2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting
Palandri F.;Paoli C.;RICCO, ALESSANDRA;Vannucchi A. M.;
2018
Abstract
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting
| File | Dimensione | Formato | |
|---|---|---|---|
|
de stefano3.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
DRM non definito
Dimensione
525.57 kB
Formato
Adobe PDF
|
525.57 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
